What is the 13F Pro Quality Score for ALGN?

13F Pro ranks ALIGN TECHNOLOGY INC (ALGN) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ALGN's current score at https://13fpro.ai/research/ALGN (free sign-up required for the full ranking).

Which hedge funds own the most ALGN stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ALGN include VANGUARD CAPITAL MANAGEMENT, BlackRock,, Capital World Investors. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/ALGN as soon as new 13F filings post.

Where does 13F Pro source ALGN data?

All ALIGN TECHNOLOGY INC fundamentals and ownership data come directly from SEC EDGAR. ALIGN TECHNOLOGY INC files with the SEC under CIK 1097149. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ALGN in?

ALIGN TECHNOLOGY INC (ALGN) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ALGN research updated on 13F Pro?

ALGN's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ALIGN TECHNOLOGY INC(ALGN)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1097149 ALGN stock profile & AI dashboard →

13F Pro Quality Score

58.2/100

Rank #994 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

37.9/100

Profitability

62.9/100

Balance Sheet

75.9/100

Earnings Quality

32.0/100

Free Cash Flow

64.6/100

Institutional Flow

55.6/100

Revenue Scale

74.7/100

Dilution Risk

27.1/100

ALGN Stock Analysis & AI Quality Score

AI stock analysis and institutional research for ALIGN TECHNOLOGY INC (ALGN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALGN at 58.2/100 on a 32-signal composite quality model, placing it at rank #994 of 2,879 stocks — the top half of the AI-ranked universe. ALGN scores in the top quartile across balance sheet strength (75.9). Areas of concern include earnings quality (32.0) and revenue growth (37.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 27.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), ALIGN TECHNOLOGY INC reports quarterly revenue of $1.0B, net income of $112.8M, an operating margin of 13.7%. Top institutional holders of ALGN by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, BlackRock,, Capital World Investors, based on the most recent SEC filings. ALGN trades on the Nasdaq exchange and files with the SEC under CIK 1097149. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ALIGN TECHNOLOGY INC directly from SEC EDGAR. ALIGN TECHNOLOGY INC's 13F Pro composite quality score has ranged between 8 and 81 since 2021, currently 58.2 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.

✦

Fun facts about ALIGN TECHNOLOGY INC

Quirks, history, and lore behind ALGN — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. medical device company · mid-to-large cap · listed on Nasdaq · headquartered in Arizona.
2
The Numbers
Annual revenue roughly $4 billion, with customers in over 100 countries — proving that vanity is a global market.
3
The History
Founded in the late 1990s by two Stanford MBA students who reportedly hated their own metal braces and decided to disrupt a centuries-old profession.
4
The Secret
It doesn't just sell a product — it sells a doctor-exclusive ecosystem, locking orthodontists and dentists into its proprietary digital treatment platform.
5
The Lore
It pioneered the use of 3D printing and computer modeling in orthodontics and has manufactured well over 10 million patient treatments since launch.
6
The Giveaway
No metal. No wires. Just a series of clear removable plastic aligners that straighten teeth — and the company that invented the whole Invisalign category.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$1.0B

Net Income

Q1 2026

$112.8M

Free Cash Flow

Q1 2026

$120.3M

Operating Margin

Q1 2026

13.7%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+3.5% YoY

$4.00BFY 2024

FY21 $3.95BFY22 $3.73BFY23 $3.86BFY24 $4.00B

Net Income

-5.4% YoY

$421.0MFY 2024

FY21 $772.0MFY22 $361.6MFY23 $445.0MFY24 $421.0M

Operating Income

-5.6% YoY

$607.6MFY 2024

FY21 $976.4MFY22 $642.6MFY23 $643.3MFY24 $607.6M

EPS (Diluted)

-3.3% YoY

$5.62FY 2024

FY21 $9.69FY22 $4.61FY23 $5.81FY24 $5.62

Total Assets

+2.1% YoY

$6.21BFY 2024

FY21 $5.94BFY22 $5.95BFY23 $6.08BFY24 $6.21B

Op. Cash Flow

-6.1% YoY

$738.2MFY 2024

FY21 $1.17BFY22 $568.7MFY23 $785.8MFY24 $738.2M

Metric	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	$4.00B +3.5%	$3.86B +3.4%	$3.73B -5.5%	$3.95B +59.9%	$2.47B +2.7%	$2.41B
Net Income	$421.0M -5.4%	$445.0M +23.1%	$361.6M -53.2%	$772.0M -56.5%	$1.78B +301.1%	$442.8M
Operating Income	$607.6M -5.6%	$643.3M +0.1%	$642.6M -34.2%	$976.4M +152.2%	$387.2M -28.6%	$542.5M
EPS (Diluted)	$5.62 -3.3%	$5.81 +26.0%	$4.61 -52.4%	$9.69 -56.8%	$22.41 +305.2%	$5.53
Total Assets	$6.21B +2.1%	$6.08B +2.3%	$5.95B +0.1%	$5.94B +23.0%	$4.83B +93.1%	$2.50B
Operating Cash Flow	$738.2M -6.1%	$785.8M +38.2%	$568.7M -51.5%	$1.17B +77.1%	$662.2M -11.4%	$747.3M

AI Insight: ALGN Financial Trends

ALGN revenue remains flat at ~$1B quarterly with volatile profitability swings, including Q3 2025 net income collapse to $57M.

• Revenue stagnated around $1B quarterly from Q2 2024 to Q1 2026 with minimal growth trajectory.

• Net income volatility peaked with Q3 2025 drop to $57M from Q2 2025's $125M.

• Operating cash flow recovered to $151M in Q1 2026 after Q1 2025 low of $53M.

• Equity grew steadily from $3,758M in Q2 2024 to $4,149M in Q1 2026.

⚠ Operating margin compressed to 9.6% in Q3 2025, the lowest level in the dataset.

⚠ Cash flow remains erratic with wide quarterly swings from $53M to $286M range.

AI Insight: ALGN Ratio Trends

Align Technology's profitability remains volatile with operating margins swinging from 9.7% to 16.6% across recent quarters.

• Operating margin declined from 14.8% in Q4 2025 to 13.7% in Q1 2026.

• ROIC dropped from 15.3% in Q4 2025 to 13.7% in Q1 2026.

• Net profit margin compressed from 13.0% in Q4 2025 to 10.8% in Q1 2026.

⚠ Q3 2025 profitability collapse to 9.7% operating margin and 5.7% net margin suggests underlying operational challenges.

⚠ Quarterly margin volatility exceeding 600 basis points indicates earnings predictability concerns.

Get alerted when ALGN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ALIGN TECHNOLOGY INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ALGN

VANGUARD CAPITAL MANAGEMENT LLC
$752.4M4,389,119 sh
BlackRock, Inc.
$735.4M4,289,924 sh
Capital World Investors
$698.1M4,072,296 sh
Capital International Investors
$653.0M3,809,202 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$540.1M3,150,783 sh
FMR LLC
$462.9M2,700,359 sh
STATE STREET CORP
$431.4M2,516,254 sh
Ninety One UK Ltd
$382.0M2,228,214 sh
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
$326.2M1,902,905 sh
GOLDMAN SACHS GROUP INC
$307.9M1,796,251 sh

Fund	Value	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$752.4M	4,389,119
BlackRock, Inc.	$735.4M	4,289,924
Capital World Investors	$698.1M	4,072,296
Capital International Investors	$653.0M	3,809,202
VANGUARD PORTFOLIO MANAGEMENT LLC	$540.1M	3,150,783
FMR LLC	$462.9M	2,700,359
STATE STREET CORP	$431.4M	2,516,254
Ninety One UK Ltd	$382.0M	2,228,214
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC	$326.2M	1,902,905
GOLDMAN SACHS GROUP INC	$307.9M	1,796,251

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ALGN on your watchlist

Track score changes the day ALIGN TECHNOLOGY INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ALGN a good stock to buy?

13F Pro's AI-powered analysis of ALIGN TECHNOLOGY INC (ALGN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ALGN are available on the ALGN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ALGN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ALGN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ALIGN TECHNOLOGY INC's investment landscape.